The Journal of Pediatrics
Volume 152, Issue 4 , Pages 455-456 , April 2008

Removing the Mask: The Danger of Hidden Hypertension

  • Elaine M. Urbina, MD (Director)

      Affiliations

    • Corresponding Author InformationReprint requests: Elaine M. Urbina, MD, Director, Preventive Cardiology, Cincinnati Children’s Hospital Medical Center & Department of Pediatrics, University of Cincinnati, 3333 Burnet Ave, MLC 7002, Cincinnati, OH 45229.

References 

  1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl):555–576
  2. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550–1558
  3. Leoncini G, Ratto E, Viazzi F, et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med. 2005;257:454–460
  4. Sun P, Dwyer KM, Merz CN, et al. Blood pressure, LDL cholesterol, and intima-media thickness: a test of the “response to injury” hypothesis of atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20:2005–2010
  5. Daniels SR, Loggie JM, Khoury P, et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97:1907–1911
  6. Assadi F. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol. 2007;28:27–33
  7. Sorof JM, Alexandrov AV, Cardwell G, et al. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics. 2003;111:61–66
  8. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol. 1996;78:197–202
  9. Hanevold C, Waller J, Daniels S, et al. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics. 2004;113:328–333
  10. Stabouli S, Kotsis V, Papamichael C, et al. Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr. 2005;147:651–656
  11. Palatini P, Mormino P, Santonastaso M, et al. Ambulatory blood pressure predicts end-organ damage only in subjects with reproducible recordings (HARVEST Study Investigators). J Hypertens. 1999;17:465–473
  12. McNiece KL, Gupta-Malhotra M, Samuels J, et al. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension. 2007;50:392–395
  13. Maggio ABR, Aggoun Y, Marchand LM, et al. Associations among obesity, blood pressure, and left ventricular mass. J Pediatr. 2008;152:489–493
  14. Lurbe E, Torro I, Alvarez V, et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension. 2005;45:493–498
  15. Matsuoka S, Awazu M. Masked hypertension in children and young adults. Pediatr Nephrol. 2004;19:651–654
  16. Stabouli S, Kotsis V, Toumanidis S, et al. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol. 2005;20:1151–1155
  17. Verberk WJ, Thien T, de Leeuw PW. Masked hypertension: a review of the literature. Blood Press Monit. 2007;12:267–273
  18. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: aata from the general population (Pressione Arteriose Monitorate e Loro Associazioni (PAMELA) Study). Circulation. 2001;104:1385–1392
  19. Palatini P, Winnicki M, Santonastaso M, et al. Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension. Hypertension. 2004;44:170–174
  20. Palatini P, Longo D, Zaetta V, et al. Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity. J Hypertens. 2006;24:1375–1381
  21. Selenta C, Hogan BE, Linden W. How often do office blood pressure measurements fail to identify true hypertension? (An exploration of white-coat normotension). Arch Fam Med. 2000;9:533–540
  22. Graves JW, Althaf MM. Utility of ambulatory blood pressure monitoring in children and adolescents. Pediatr Nephrol. 2006;21:1640–1652

PII: S0022-3476(07)01174-2

doi: 10.1016/j.jpeds.2007.12.045

The Journal of Pediatrics
Volume 152, Issue 4 , Pages 455-456 , April 2008

Article Tools